Literature DB >> 9856688

Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment.

T Nakamura1, I Ebihara, N Shimada, H Shoji, H Koide.   

Abstract

The authors measured plasma metalloproteinase (MMP)-9 and corresponding monocyte mRNA in 20 patients with septic shock. Plasma MMP-9 concentrations and monocyte MMP-9 mRNA levels were significantly higher in the 10 nonsurviving patients with septic shock than in 10 surviving patients and 25 normal controls. Hemoperfusion using polymyxin B immobilized on fibers (PMX-F), a reportedly effective treatment for septic shock, was studied for effects on MMP-9 in the patients. Increases in plasma MMP-9 concentrations and corresponding monocyte mRNA levels were attenuated significantly by PMX-F treatment in both nonsurviving and surviving patients. These data suggest that plasma MMP-9 concentrations and monocyte MMP-9 mRNA levels may be useful prognostic markers in septic shock, and that PMX-F treatment affects MMP-9.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856688     DOI: 10.1097/00000441-199812000-00001

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  29 in total

1.  Unveiling differentially expressed genes upon regulation of transcription factors in sepsis.

Authors:  Junli Zhang; Yuelei Cheng; Minmin Duan; Nannan Qi; Jian Liu
Journal:  3 Biotech       Date:  2017-04-25       Impact factor: 2.406

2.  Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.

Authors:  M M Lalu; J Cena; R Chowdhury; A Lam; R Schulz
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

3.  Rac1 regulates platelet shedding of CD40L in abdominal sepsis.

Authors:  Rundk Hwaiz; Milladur Rahman; Enming Zhang; Henrik Thorlacius
Journal:  Lab Invest       Date:  2014-07-21       Impact factor: 5.662

4.  Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis.

Authors:  Fiia P Gäddnäs; Meeri M Sutinen; Marjo Koskela; Taina Tervahartiala; Timo Sorsa; Tuula A Salo; Jouko J Laurila; Vesa Koivukangas; Tero I Ala-Kokko; Aarne Oikarinen
Journal:  Crit Care       Date:  2010-03-31       Impact factor: 9.097

5.  Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis.

Authors:  Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Hikaru Koide
Journal:  Intensive Care Med       Date:  2004-06-12       Impact factor: 17.440

6.  Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis.

Authors:  Felipe Dal-Pizzol; Hugo Alberto Rojas; Emilia Marcelina dos Santos; Francieli Vuolo; Larissa Constantino; Gustavo Feier; Matheus Pasquali; Clarissa M Comim; Fabrícia Petronilho; Daniel Pens Gelain; João Quevedo; José Cláudio Fonseca Moreira; Cristiane Ritter
Journal:  Mol Neurobiol       Date:  2013-03-12       Impact factor: 5.590

7.  Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.

Authors:  Manoj M Lalu; Cindy Q Gao; Richard Schulz
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

8.  Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.

Authors:  Leonardo Lorente; María M Martín; Lorenzo Labarta; César Díaz; Jordi Solé-Violán; José Blanquer; Josune Orbe; José A Rodríguez; Alejandro Jiménez; Juan M Borreguero-León; Felipe Belmonte; Juan C Medina; Maria C Llimiñana; José M Ferrer-Agüero; José Ferreres; María L Mora; Santiago Lubillo; Manuel Sánchez; Ysamar Barrios; Antonio Sierra; José A Páramo
Journal:  Crit Care       Date:  2009-10-02       Impact factor: 9.097

9.  Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis.

Authors:  Leonardo Lorente; María M Martín; Jordi Solé-Violán; José Blanquer; José Antonio Páramo
Journal:  Crit Care       Date:  2010-01-19       Impact factor: 9.097

10.  Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?

Authors:  Ursula Hoffmann; Martina Brueckmann; Martin Borggrefe
Journal:  Crit Care       Date:  2009-12-01       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.